Filipinos are redefining life with diabetes, pushing past limits and proving that health challenges do not define their ...

Abbott’s FY2025 guidance shows robust growth driven by diabetes care, new product launches, and strong demand. Find out why ...

Abbott Labs reported 6.9% sales growth in Q3 2025, led by medical devices and nutrition, while reaffirming full-year guidance ...

Get key Q3 2025 earnings insights for Abbott Labs (ABT)—discover growth drivers, innovation highlights, and outlook for 2026.

ABT's Q3 earnings meet expectations as revenues climb 6.9% year over year, driven by double-digit gains in Medical Devices.

Three Filipinos in their 60s share their real life stories and suggest real solutions to dealing and living with diabetes.

Abbott Laboratories (ABT) reports robust earnings with significant contributions from medical devices and new product ...

Abbott stock fell as Q3 sales missed estimates and 2025 earnings guidance was narrowed despite solid growth in medical ...

Q3 2025 Earnings Call Transcript October 15, 2025 Abbott Laboratories reports earnings inline with expectations. Reported EPS ...

A new trial suggests that a “green Mediterranean diet” — which cuts out animal proteins in favor of plants — can lower biomarkers tied to accelerated brain aging. Participants were told to cut back on ...

Drinking as little as one can of diet soda a day may increase the risk of nonalcohol fatty liver disease by 60%, while drinking a sugary beverage could raise the risk by 50%, a new unpublished study ...